HKSH Medical Group Strengthens Collaboration with United Imaging Introducing Hong Kong’s First Total-Body PET/CT System to Strengthen “Dual-Tracer” in Nuclear Medicine and Advance Innovation in Cancer Theranostics

(Hong Kong, 23 September 2026) — HKSH Medical Group (HKSH) has long been committed to advancing precision medicine. In the field of cancer diagnosis, HKSH actively introduces innovative technologies and promotes clinical research to support the most accurate clinical diagnosis and treatment planning, where nuclear medicine is an indispensable medical specialty in modern cancer diagnosis and treatment. To further expand its technological capabilities, HKSH Cancer Centre has introduced Hong Kong’s first long axial total-body PET/CT system, developed by United Imaging Healthcare (United Imaging). The system enables highly sensitive whole-body dynamic imaging combining low radiation exposure, efficiency and high precision. In a single imaging examination, it can accurately track small early-stage cancer lesions and hidden metastatic cancer cells throughout the body, significantly enhancing diagnostic effectiveness and helping physicians formulate targeted precision treatment plans.